Senior insider sale
VIKING THERAPEUTICS, INC. — senior position signals high conviction
$1.20M
20.79K shares
What this filing means
SINGLETON J MATTHEW plans to sell 20.79K shares of VIKING THERAPEUTICS, INC. valued at approximately $1.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2024ACC: 0000103623-24-000070
Director
Since Jan 2019
20.79K
Shares to sell
$1.20M
Approx. market value
20.79K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
NQSO Grant
n/a
4/28/2015
20.79KTotal acquired20.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/28/2015 | NQSO Grant n/a | 20.79K | — |
| Total | 20.79K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
20.79K
Market value
$1.20M
8/14/2024
Total
Units
20.79K
Value
$1.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2024 | 20.79K | $1.20M | NASDAQ | Planned |
| Total | 20.79K | $1.20M | ||